These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
822 related articles for article (PubMed ID: 31856858)
21. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer. Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095 [TBL] [Abstract][Full Text] [Related]
22. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer. Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903 [TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival. Michaelidou K; Ardavanis A; Scorilas A Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606 [TBL] [Abstract][Full Text] [Related]
24. Clinical implications of high NQO1 expression in breast cancers. Yang Y; Zhang Y; Wu Q; Cui X; Lin Z; Liu S; Chen L J Exp Clin Cancer Res; 2014 Feb; 33(1):14. PubMed ID: 24499631 [TBL] [Abstract][Full Text] [Related]
25. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer. Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452 [TBL] [Abstract][Full Text] [Related]
27. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report. You Y; Li H; Qin X; Zhang Y; Song W; Ran Y; Gao F Cell Oncol (Dordr); 2015 Dec; 38(6):485-91. PubMed ID: 26392360 [TBL] [Abstract][Full Text] [Related]
28. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer. Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369 [TBL] [Abstract][Full Text] [Related]
29. Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression. Huang Z; Li X; Xie T; Gu C; Ni K; Yin Q; Cao X; Zhang C Cancer Res Treat; 2020 Oct; 52(4):1067-1083. PubMed ID: 32599985 [TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949 [TBL] [Abstract][Full Text] [Related]
31. Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool. dos-Santos PB; Zanetti JS; Vieira-de-Mello GS; Rêgo MB; Ribeiro-Silva A A; Beltrão EI Int J Clin Exp Pathol; 2014; 7(5):2337-49. PubMed ID: 24966944 [TBL] [Abstract][Full Text] [Related]
32. [Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type]. Yue M; Li F; Deng HY; Zhang LL; Liu YP Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):754-758. PubMed ID: 29061019 [No Abstract] [Full Text] [Related]
33. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer. Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201 [TBL] [Abstract][Full Text] [Related]
34. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer. Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481 [TBL] [Abstract][Full Text] [Related]
35. Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer. Chen JQ; Litton J; Xiao L; Zhang HZ; Warneke CL; Wu Y; Shen X; Wu S; Sahin A; Katz R; Bondy M; Hortobagyi G; Berinstein NL; Murray JL; Radvanyi L Horm Cancer; 2010 Feb; 1(1):21-33. PubMed ID: 21761348 [TBL] [Abstract][Full Text] [Related]
36. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014). De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139 [TBL] [Abstract][Full Text] [Related]
37. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer. Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746 [TBL] [Abstract][Full Text] [Related]
38. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast. Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804 [TBL] [Abstract][Full Text] [Related]
39. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas. Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741 [TBL] [Abstract][Full Text] [Related]
40. Prognostic and biological significance of microRNA-127 expression in human breast cancer. Wang S; Li H; Wang J; Wang D; Yao A; Li Q Dis Markers; 2014; 2014():401986. PubMed ID: 25477702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]